Current Research in Translational Medicine
Overview
Current Research in Translational Medicine is a peer-reviewed journal that focuses on the latest advancements in the field of translational medicine. It publishes original research articles, reviews, and case studies that bridge the gap between basic science and clinical applications, aiming to accelerate the translation of scientific discoveries into improved patient care. The journal covers a wide range of topics including drug development, biomarkers, personalized medicine, and innovative therapeutic approaches, providing a platform for researchers and clinicians to share their findings and
Details
Details
Abbr.
Curr Res Transl Med
Start
2016
End
Continuing
Frequency
Quarterly
e-ISSN
2452-3186
Country
France
Language
English
Metrics
Metrics
h-index / Ranks: 5406
67
SJR / Ranks: 4122
953
CiteScore / Ranks: 3626
6.20
JIF / Ranks: 2178
4.1
Recent Articles
1.
Bergonzi G, Campochiaro C, Tomelleri A, Del Poggio A, Bonacchi R, Ferre L, et al.
Curr Res Transl Med
. 2025 Mar;
73(3):103505.
PMID: 40086416
No abstract available.
2.
Tallima Z, Ibraheem D, Wilson M, Elfishawi S
Curr Res Transl Med
. 2025 Mar;
73(2):103503.
PMID: 40058172
The strong association between NPM1 mutation and increased expression levels of HOXA7 and HOXA9 implies that HOXA genes may be utilized as targeted treatment markers in NPM1-mutated patients. We examined...
3.
Dey R, Das A
Curr Res Transl Med
. 2025 Mar;
73(2):103504.
PMID: 40054039
Psoriasis is a chronic inflammatory skin disease characterized by red lesions and skin patches with silvery scales. Overall, 2 - 3 % of the worldwide population is affected by psoriasis....
4.
Song K, Wu Y, Tan S
Curr Res Transl Med
. 2025 Feb;
73(1):103502.
PMID: 39985853
Recent studies prove that the three well-established cell death pathways-pyroptosis, apoptosis, and necroptosis-are not isolated but rather engage in extensive crosstalk. PANoptosis, a newly identified pathway of inflammatory regulated cell...
5.
Zhou S, Ma C, Zhou D, Zhu Q, Zhu W, Li J, et al.
Curr Res Transl Med
. 2025 Feb;
73(1):103501.
PMID: 39970787
Introduction: Research on anti-lymphocyte globulins other than rabbit anti-thymocyte globulin (r-ATG) in prevention of graft-versus-host-disease (GVHD) following HLA-matched siblings hematopoietic stem cell transplantation (MSD-HSCT) is limited. The objective of this...
6.
Ismail S, Hamed F, Alsuliman T, Al-Tameemi K
Curr Res Transl Med
. 2025 Feb;
73(1):103497.
PMID: 39965472
No abstract available.
7.
Simon L, Caulier A, Berthon C, Boyer T, Harrivel V, Joris M, et al.
Curr Res Transl Med
. 2025 Feb;
73(2):103500.
PMID: 39947092
Older adults with acute myeloid leukemia (AML) have a poor prognosis because frailty and the characteristics of the disease limit the use of intensive chemotherapy (ICT). Treatment with 5-azacitidine (5-AZA)...
8.
Ramalakshmi N, Thirunavukkarasu M, Shaik F, Navami K, Krishnamurthy R
Curr Res Transl Med
. 2025 Feb;
73(2):103498.
PMID: 39938184
SARS-CoV-2 infection has been associated with long-term cardiovascular complications including myocarditis and heart failure, as well as central nervous system sequelae such as cognitive dysfunction and neuropathy. Proprotein convertase subtilisin/Kexin...
9.
Lazzari L, Catalano G, Bruno A, Sannipoli D, Lupo-Stanghellini M, Peccatori J, et al.
Curr Res Transl Med
. 2025 Feb;
73(2):103499.
PMID: 39923313
Graft-versus-host disease (GvHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (alloHCT) and optimal approaches for its prevention have been recently updated. Post-transplant cyclophosphamide...
10.
Moka M, George M, Rathakrishnan D, Jagadeeshwaran V, K S
Curr Res Transl Med
. 2025 Jan;
73(2):103496.
PMID: 39847829
Drug repurposing is a promising strategy for managing cardiovascular disease (CVD) in geriatric populations, offering efficient and cost-effective solutions. CVDs are prevalent across all age groups, with a significant increase...